6-(4H-1,2,4-triazol-3-ylthio)-3-(6-methylpyridin-3-ylthio)-N-(1,2,4-thiadiazol-5-yl)picolinamide

ID: ALA4079100

PubChem CID: 10365275

Max Phase: Preclinical

Molecular Formula: C16H12N8OS3

Molecular Weight: 428.53

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  Cc1ccc(Sc2ccc(Sc3nnc[nH]3)nc2C(=O)Nc2ncns2)cn1

Standard InChI:  InChI=1S/C16H12N8OS3/c1-9-2-3-10(6-17-9)26-11-4-5-12(27-16-18-7-20-24-16)22-13(11)14(25)23-15-19-8-21-28-15/h2-8H,1H3,(H,18,20,24)(H,19,21,23,25)

Standard InChI Key:  JADPOZIPXGRFTI-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 28 31  0  0  0  0  0  0  0  0999 V2000
    4.2372   -3.4379    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2361   -4.2575    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9441   -4.6664    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6538   -4.2570    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6510   -3.4343    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9424   -3.0291    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.5294   -3.0295    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    2.8218   -3.4383    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0739   -3.1059    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.5272   -3.7133    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9360   -4.4210    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.7353   -4.2507    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.3622   -4.6645    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    6.3634   -5.4817    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6551   -5.8898    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6560   -6.7063    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3649   -7.1146    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0743   -6.7005    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.0699   -5.8854    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3673   -7.9317    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3571   -3.0231    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0664   -3.4290    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.3541   -2.2059    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.7725   -3.0178    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5196   -3.3461    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.0642   -2.7368    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6529   -2.0305    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.8542   -2.2036    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  1  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12  8  2  0
  4 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 14  1  0
 17 20  1  0
  5 21  1  0
 21 22  1  0
 21 23  2  0
 22 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 24  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA4079100

   6-((4h-1,2,4-triazol-3-yl)thio)-3-((6-methylpyridin-3-yl)thio)-N-(1,2,4-thiadiazol-5-yl)picolinamide

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 428.53

Molecular Weight (Monoisotopic): 428.0296

AlogP: 3.31

#Rotatable Bonds: 6

Polar Surface Area: 122.23

Molecular Species: NEUTRAL

HBA: 10

HBD: 2

#RO5 Violations: ┄

HBA (Lipinski): 9

HBD (Lipinski): 2

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 6.97

CX Basic pKa: 4.93

CX LogP: 2.77

CX LogD: 2.20

Aromatic Rings: 4

Heavy Atoms: 28

QED Weighted: 0.48

Np Likeness Score: -1.77

References

1. Xu J, Lin S, Myers RW, Trujillo ME, Pachanski MJ, Malkani S, Chen HS, Chen Z, Campbell B, Eiermann GJ, Elowe N, Farrer BT, Feng W, Fu Q, Kats-Kagan R, Kavana M, McMasters DR, Mitra K, Tong X, Xu L, Zhang F, Zhang R, Addona GH, Berger JP, Zhang B, Parmee ER..  (2017)  Discovery of orally active hepatoselective glucokinase activators for treatment of Type II Diabetes Mellitus.,  27  (9): [PMID:28284809] [10.1016/j.bmcl.2016.10.088]

Source

Source(1):

• Scientific Literature